menu

Our Media Partners

JackLeckerman Company is dedicated to increasing access to medicines across Latin America and emerging markets by fostering collaboration between government officials, healthcare stakeholders, and the pharmaceutical industry. As a leading business event organizer, JL specializes in international summits, strategic conferences, executive forums, and professional training programs for the pharmaceutical and biotechnology sectors across Latin America, Africa, Europe, and North America.

Our biosimilars-focused forums promote the development, adoption, and accessibility of biosimilars by addressing key industry challenges, facilitating knowledge exchange, and encouraging strategic dialogue among regulators, policymakers, manufacturers, payers, healthcare professionals, and patient advocates.

JackLeckerman will host the following biosimilars forums:

Through these initiatives, JackLeckerman continues to support regional and global collaboration, helping advance sustainable biosimilars markets and improve patient access to high-quality biologic therapies worldwide.

Generics and Biosimilars Initiative (GaBI) was founded in 2008. GaBI aims to foster the worldwide efficient use of high quality and safe medicines at an affordable price, thus advancing and supporting the idea of accessible, affordable and sustainable health care.

The objective of GaBI is to raise the scientific status of generic and biosimilar medicines, via well-documented and up-to-date information about generic and biosimilar medicines both in print (www.gabi-journal.net) and electronically (www.gabionline.net) in an open access format, providing high quality, scientifically sound and reliable information to healthcare professionals including physicians, pharmacists and nurses, consumers, drug developers, third-party payers, legislators and assessors; who are in need of a reliable, critical and independent source of information on all aspects of generic and biosimilar medicines.

Subscribe to gain easy access of information on the latest scientific research and developments in generic and biosimilar medicines via GaBI Online to editorial@gabionline.net; or submit a manuscript to GaBI Journal to editorial@gabi-journal.net.

GaBI’s mission – Building trust in cost-effective treatments

Part of Norstella's wider News & Insights portfolio, Generics Bulletin delivers in-depth news and analysis on the latest regulatory, legal, market, and commercial developments in the global generics, biosimilars, and value-added medicines industries.

Biosimilars review & Report (BR&R) provides education, commentary and updates on the biosimilar marketplace. Visit https://biosimilarsrr.com/ for a frequently updated resource on the entire field, including biosimilar product profiles, approvals and policy and coverage decisions. We publish regular blogs you can subscribe to receive notifications of new posts by email.

A unique organization, American Conference Institute (ACI) is devoted to providing the business intelligence that senior decision-makers need to respond to challenges around the world. Staffed by industry specialists, lawyers and other professionals, ACI operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge. To learn more about our event offerings, click here.

The Festival of Biologics Basel is Europe’s largest biologics conference and exhibition. The event is for the leaders of the world’s biologic drug developers and their most senior executives in charge of the latest tech and strategies that are driving the industry forward. Join us in Basel for 2025!

Book your ticket now: www.terrapinn.com/fob25/gbw
Date: 30th September 2025 - 2 October 2025
Venue: Messe Basel, Switzerland
Hashtag:  #festivalofbiologics

CONTACT US
IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION
C/O DYN SA - Rue de Cornavin 11 - 1201 Geneva, Switzerland